Bharat Biotech’s intra-nasal COVID vaccine gets emergency use approval
Bharat Biotech’s ChAd36-SARS-CoV-S COVID-19 (Chimpanzee Adenovirus Vectored) recombinant nasal vaccine has been approved by Central Drugs Standard Control Organisation (CDSCO) for primary immunization against COVID-19 in 18+ age group for restricted use in emergencies, Health Minister Mansukh Mandaviya tweeted on Tuesday. This is India’s first intranasal vaccine for COVID-19.
Asia Cup, Super 4 | Men in Blue on the brink of elimination after losing to Sri Lanka